NO BAGIAN JUMLAH SAMPEL JUMLAH PASIEN YANG MENGGUNAKAN JUMLAH SAMPEL

PASIEN (RM) ANTIBIOTIK PASIEN (RM)

N %
1 BAGIAN ANAK 408 322 78.92% 732
2 BAGIAN 577 416 72.10% 581
PENYAKIT
DALAM
3 BAGIAN BEDAH 336 301 89.58% 310
4 BAGIAN 425 192 45.17% 484
5 OBSGYN
BAGIAN LAIN 208 171 82.21% 199
JUMLAH 1,954 1,402 71.75% 2,306

JUMLAH SAMPEL JUMLAH PASIEN YANG MENGGUNAKAN

PASIEN (RM) ANTIBIOTIK

NO BAGIAN N %
1 BAGIAN ANAK 2792 1389 49.749
2 BAGIAN 2882 2041 70.819
PENYAKIT
DALAM
3 BAGIAN BEDAH 1316 1258 95.593
4 BAGIAN 2142 855 39.916
5 OBSGYN
BAGIAN LAIN 1005 653 64.975
JUMLAH 10,137 6,196 61.123

NO BAGIAN PASIEN DENGAN ANTIBIOTIK (%)

1 ANAK 49.75
2 P DALAM 70.82
3 BEDAH 95.6
4 OBSGYN 39.92
5 LAINNYA 64.98

TRIWULAN (%)
NO BAGIAN I II III IV
 1 ANAK 78.92 42.76 40.03 48.73
2 PENYAKIT DALAM 72.10 73.15 75.23 66.2
3 BEDAH 89.58 90.97 88.21 88.07
4 OBSGYN 45.17 27.89 48.17 38.15
5 LAINNYA 82.21 77.39 61.05 49.85

NAMA ANTIBIOTIK NILAI TOTAL DDD (%)

NO BAGIAN TERTINGGI I TERTINGGI II TERTINGGI I TERTINGGI II
1 ANAK Ceftriaxone IV Cefotaxime IV 30.54 2.72
2 PD Levofloxacin IV Azithromycin PO 55.46 53.92
3 BEDAH Ceftriaxone IV Metronidazol IV 36.11 10.03
4 OBSGYN Erithromycin PO Amoxicillin PO 18.52 14.29
5 LAINNYA Levofloxacin IV Azithromycin PO 50.22 39.83

NO ANTIBIOTIK JUMLAH PASIEN NILAI DDD TOTAL LOS %

1 AMOXICILLIN PO 96 145.33 1674 100
2 AZITHROMYCIN P 3 15 1674 100
3 CEFADROXIL PO 3 2 1674 100
4 CEFAZOLIN IV 96 66.33 1674 100
5 CEFIXIME PO 2 3 1674 100
6 CEFTRIAXONE IV 90 165.5 1674 100
7 CO AMOXICLAV P 14 24.6 1674 100
8 ERITHROMYCIN P 75 281.5 1674 100
9 METRONIDAZOLE 80 117.5 1674 100
10 METRONIDAZOLE 90 111.2 1674 100
JUMLAH PASIEN JUMLAH JUMLAH PASIEN
YANG SAMPEL YANG JUMLAH PASIEN
MENGGUNAKAN PASIEN MENGGUNAKAN YANG
ANTIBIOTIK (RM) ANTIBIOTIK JUMLAH
SAMPEL MENGGUNAKAN
PASIEN ANTIBIOTIK
N % N % (RM) N %
313 42.76 587 235 40.03 1065 519 48.73
425 73.15 650 489 75.23
1074 711 66.2
282 90.97 280 247 88.21 486 428 88.07
135 27.89 575 277 48.17 658 251 38.15
154 77.39 267 163 61.05 331 165 49.85
1,309 56.76 2,359 1,411 59.81 3614 2074 57.39

PENGGUNAAN ANTIBIOTIK SECARA ACAK

TAHUN 2021
95.6
100
90
100 80 70.82
64.98
70 PASIEN
60 49.75 DENGAN
50 39.92 ANTIBIOTIK
(%)
40
30
20
10
0
ANAK P DALAM BEDAH OBSGYN LAINNYA

100
90
80
70
60
50 II
III
 100
90
80
70
60
50 II
40 III
IV
30
20
10
0
78.92 72.10 89.58 45.17 82.21
ANAK PENYAKIT BEDAH OBSGYN LAINNYA
DALAM

NILAI
TOTAL
DDD
8.682
0.896 AUDIT KUANTITATIF PENGGUNAAN ANTIBIOTIK DEN-
0.119 GAN METODE DDD SECARA ACAK PADA BAGIAN OB-
3.963 SGYN TRIWULAN II TAHUN 2021
0.179
2000
9.886
1500
1.469
1000
16.816
500 8.682 0.896 0.119 3.963 0.179 9.886 1.469 16.816 7.019 6.
7.019
0
6.641
PO PO O IV O IV PO PO PO IV
N N I LP LI
N EP E V N LE LE
LL
I
YC
I
OX IM ON LA YC
I
ZO ZO
CI ZO X X IC A
I M DR A FI IA M A D
OX R O
FA CE
F
CE FT
R OX R O I D NI
H E CE AM H ON RO
AM IT C IT R ET
AZ CO ER ET M
M
JUMLAH PASIEN
AAN ANTIBIOTIK DEN-
AK PADA BAGIAN OB-
AHUN 2021

9.886 1.469 16.816 7.019 6.641

IV PO PO PO IV
V I N LE LE
LA YC ZO ZO
IC M A D A
OX R O I D NI
AM IT
H
R ON RO
ER ET ET
M M

N
 TOTAL
NILAI TOTAL NILAI
NO KODE ATC NAMA ANTIBIOTIK DDD ALL LOS % DDD NO
1 J01GB06 AMIKASIN IV 0.22 8693 100 0.003 1
2 J01CA04 AMOXICILLIN IV 2 8693 100 0.023 2
3 J01CA04 AMOXICILLIN PO 205.5 8693 100 2.364 3
4 J01CA01 AMPICILIN IV 0 8693 100 0 4
5 J01CA01 AMPICILIN SULBACTAM IV 0 8693 100 0 5
6 J01MB03 ASAM PIPEMIDIC PO 11 8693 100 0.127 6
7 J01FA10 AZITHROMICIN PO 2292.43 8693 100 26.371 7
8 J01DB05 CEFADROXIL PO 7.2 8693 100 0.083 8
9 J01DB04 CEFAZOLIN IV 76.67 8693 100 0.882 9
10 J01DD08 CEFIXIME PO 85.09 8693 100 0.979 10
11 J01DD12 CEFOPERAZONE IV 0 8693 100 0 11
12 J01DD12 CEFOPERAZONE-SULBACTAM IV 13 8693 100 0.15 12
13 J01DD01 CEFOTAXIME IV 140.3 8693 100 1.614 13
14 J01DD02 CEFTAZIDIM IV 144.28 8693 100 1.66 14
15 J01DD04 CEFTRIAXONE IV 1660.15 8693 100 19.098 15
16 J01DC02P CEFUROXIME IV 148.67 8693 100 1.71 16
17 J01MA02P CIPROFLOXACIN IV 84.5 8693 100 0.972 17
18 J01MA02 CIPROFLOXACIN PO 160 8693 100 1.841 18
19 J01FA09 CLARITHROMICIN PO 4 8693 100 0.046 19
20 J01FF01 CLINDAMICIN PO 73 8693 100 0.84 20
21 J01CR02 CO AMOXICLAV IV 24.33 8693 100 0.28 21
22 J01CR02 CO AMOXICLAV PO 17.3 8693 100 0.199 22
23 J01EE01 COTRIMOXAZOL PO 78.97 8693 100 0.908 23
24 J01GB09 DIBEKASIN IV 10 8693 100 0.115 24
25 J01AA02 DOXICYCLINE PO 30 8693 100 0.345 25
26 J01FA01 ERITHROMICIN PO 256 8693 100 2.945 26
27 J04AK02 ETAMBUTOL PO 162.71 8693 100 1.872 27
28 J01XX01 FOSFOMYCIN IV 0 8693 100 0 28
29 J01GB03 GENTAMICIN IV 42.03 8693 100 0.483 29
30 J04AC01 IMIPENEM-CILASTATIN IV 0 8693 100 0 30
31 J01DH51 ISONIAZID PO 248.66 8693 100 2.86 31
32 J01GB04 KANAMICIN IV 8 8693 100 0.092 32
33 J01BA01 KHLORAMPENICOL IV 0 8693 100 0 33
34 J01BA02 KHLORAMPENICOL PO 0 8693 100 0 34
35 J01MA12 LEVOFLOXACIN IV 2474 8693 100 28.46 35
36 J01MA12 LEVOFLOXACIN PO 183 8693 100 2.105 36
37 J01FF02 LINKOMYCIN PO 32.5 8693 100 0.374 37
38 J01DH02 MEROPENEM IV 94.32 8693 100 1.085 38
39 J01XD01 METRONIDAZOL IV 332.75 8693 100 3.828 39
40 P01AB01 METRONIDAZOL PO 187.15 8693 100 2.153 40
 41 J01MA01 OFLOXACIN PO 0 8693 100 0 41
42 J01CA12 PIPERACILLIN-TAZOBACTAM IV 7.4 8693 100 0.085 42
43 J04AK01 PYRAZINAMID PO 105.7 8693 100 1.216 43
44 J04AB02 RIFAMPISIN PO 162.75 8693 100 1.872 44
45 J01F02 SPIRAMICIN PO 24 8693 100 0.276 45
46 J01BA02 THIAMPENICOL PO 70.83 8693 100 0.815 46
47 J01XA01 VANCOMYCIN IV 1 8693 100 0.012 47

NILAI DDD PER TRIWULAN (%) NILAI DDD

NO KODE ATC NAMA ANTIBIOTIK
I II III IV (%)
1 J01GB06 AMIKASIN IV 0.22 0.45 0.8 2.14 3.61
2 J01CA04 AMOXICILLIN IV 2 2 0 2 6
3 J01CA04 AMOXICILLIN PO 205.5 159.66 159.95 228.9 754.01
4 J01CA01 AMPICILIN IV 0 0 0 0 0
5 J01CA01 AMPICILIN SULBACTAM IV 0 14.5 0 2.25 16.75
6 J01MB03 ASAM PIPEMIDIC PO 11 0 7 33 51
7 J01FA10 AZITHROMICIN PO 2292.43 2245.83 1984.87 48.55 6571.68
8 J01DB05 CEFADROXIL PO 7.2 4.88 2.5 2.14 16.72
9 J01DB04 CEFAZOLIN IV 76.67 67.66 58.87 146 349.2
10 J01DD08 CEFIXIME PO 85.09 53.3 60.75 81.36 280.5
11 J01DD12 CEFOPERAZONE IV 0 6.5 2.5 32.5 41.5
12 J01DD12 CEFOPERAZONE-SULBACTAM IV 13 7 2 24 46
13 J01DD01 CEFOTAXIME IV 140.3 136.9 131.5 202.13 610.83
14 J01DD02 CEFTAZIDIM IV 144.28 146 92.5 88.14 470.92
15 J01DD04 CEFTRIAXONE IV 1660.15 1589.01 1536.48 2842.83 7628.47
16 J01DC02P CEFUROXIME IV 148.67 194 211.34 229.03 783.04
17 J01DC02P CEFUROXIME PO 0 0 0.33 0 0.33
18 J01MA02P CIPROFLOXACIN IV 84.5 103 141 200.5 529
19 J01MA02 CIPROFLOXACIN PO 160 192.8 250 514.8 1117.6
20 J01FA09 CLARITHROMICIN PO 4 18 2 1.02 25.02
21 J01FF01 CLINDAMICIN PO 73 58.55 111.75 141.05 384.35
22 J01CR02 CO AMOXICLAV IV 24.33 0 0 0 24.33
23 J01CR02 CO AMOXICLAV PO 17.3 49.6 5.58 12.5 84.98
24 J01EE01 COTRIMOXAZOL PO 78.97 48.25 59.77 110.11 297.1
25 J01GB09 DIBEKASIN IV 10 11.43 1.43 2.86 25.72
26 J01AA02 DOXICYCLINE PO 30 70 104 144 348
27 J01FA01 ERITHROMICIN PO 256 288.94 246.85 338.9 1130.69
28 J04AK02 ETAMBUTOL PO 162.71 121.57 157.59 494.67 936.54
29 J01XX01 FOSFOMYCIN IV 0 0 0 0 0
30 J01GB03 GENTAMICIN IV 42.03 24.35 24.87 47.07 138.32
31 J04AC01 IMIPENEM-CILASTATIN IV 0 0 0 0 0
32 J01DH51 ISONIAZID PO 248.66 184.51 241.84 1141.5 1816.51
33 J01GB04 KANAMICIN IV 8 0 9 4 21
34 J01BA01 KHLORAMPENICOL IV 0 15.53 7.3 0 22.83
35 J01BA02 KHLORAMPENICOL PO 0 0 0 0 0
36 J01MA12 LEVOFLOXACIN IV 2474 2349.5 2466 789 8078.5
37 J01MA12 LEVOFLOXACIN PO 183 105 95 49.5 432.5
38 J01FF02 LINKOMYCIN PO 32.5 31.7 24.17 48.3 136.67
39 J01DH02 MEROPENEM IV 94.32 211.29 204.19 89.75 599.55
40 J01XD01 METRONIDAZOL IV 332.75 291.88 349.01 360.8 1334.44
41 P01AB01 METRONIDAZOL PO 187.15 150.61 163.27 163.28 664.31
42 J01MA01 OFLOXACIN PO 0 0 2 10 12
43 J01CA12 PIPERACILLIN-TAZOBACTAM IV 7.4 0 18.32 11.57 37.29
44 J04AK01 PYRAZINAMID PO 105.7 24.2 101.1 289.2 520.2
45 J04AB02 RIFAMPISIN PO 162.75 112.92 166.26 474.08 916.01
46 J01F02 SPIRAMICIN PO 24 62 29.5 133 248.5
47 J01BA02 THIAMPENICOL PO 70.83 84 43 59 256.83
48 J01XA01 VANCOMYCIN IV 1 0 0 0 1
 NILAI DDD ALL TOTAL
KODENAMAATC ANTIBIOTIK LOS % TOTAL NILAI DDD NO
J01GB06 AMIKASI 0.45 9757 100 0.005 1
J01CA04 AMOXICI 2 9757 100 0.02 2
J01CA04 AMOXICI 159.66 9757 100 1.636 3
J01CA01 AMPICILI 0 9757 100 0 4
J01CA01 AMPICIL 14.5 9757 100 0.149 5
J01MB03 ASAM PI 0 9757 100 0 6
J01FA10 AZITHRO 2245.83 9757 100 23.018 7
J01DB05 CEFADRO 4.88 9757 100 0.05 8
J01DB04 CEFAZOL 67.66 9757 100 0.693 9
J01DD08 CEFIXIM 53.3 9757 100 0.546 10
J01DD12 CEFOPER 6.5 9757 100 0.067 11
J01DD12 CEFOPER 7 9757 100 0.072 12
J01DD01 CEFOTAX 136.9 9757 100 1.403 13
J01DD02 CEFTAZI 146 9757 100 1.496 14
J01DD04 CEFTRIA 1589.01 9757 100 16.286 15
J01DC02P CEFUROX 194 9757 100 1.988 16
J01MA02P CIPROFL 103 9757 100 1.056 17
J01MA02 CIPROFL 192.8 9757 100 1.976 18
J01FA09 CLARITH 18 9757 100 0.184 19
J01FF01 CLINDAM 58.55 9757 100 0.6 20
J01CR02 CO AMO 0 9757 100 0 21
J01CR02 CO AMO 49.6 9757 100 0.508 22
J01EE01 COTRIM 48.25 9757 100 0.495 23
J01GB09 DIBEKASI 11.43 9757 100 0.117 24
J01AA02 DOXICYC 70 9757 100 0.717 25
J01FA01 ERITHRO 288.94 9757 100 2.961 26
J04AK02 ETAMBU 121.57 9757 100 1.246 27
J01XX01 FOSFOMY 0 9757 100 0 28
J01GB03 GENTAMI 24.35 9757 100 0.25 29
J04AC01 IMIPENE 0 9757 100 0 30
J01DH51 ISONIAZ 184.51 9757 100 1.891 31
J01GB04 KANAMIC 0 9757 100 0 32
J01BA01 KHLORAM 15.53 9757 100 0.159 33
J01BA02 KHLORA 0 9757 100 0 34
J01MA12 LEVOFLO 2349.5 9757 100 24.08 35
J01MA12 LEVOFLO 105 9757 100 1.076 36
J01FF02 LINKOMY 31.7 9757 100 0.325 37
J01DH02 MEROPE 211.29 9757 100 2.166 38
J01XD01 METRONI 291.88 9757 100 2.991 39
P01AB01 METRON 150.61 9757 100 1.544 40
J01MA01 OFLOXAC 0 9757 100 0 41
J01CA12 PIPERAC 0 9757 100 0 42
J04AK01 PYRAZIN 24.2 9757 100 0.248 43
J04AB02 RIFAMPI 112.92 9757 100 1.157 44
J01F02 SPIRAMI 62 9757 100 0.635 45
J01BA02 THIAMPE 84 9757 100 0.861 46
J01XA01 VANCOMY 0 9757 100 0 47

TOTAL TOTAL NILAI

LOS % DDD (%) NO NAMA ANTIBIOTIK TOTAL NILAI DDD (%)
41396 100 0.009 1 AMOXICILLIN PO 1.82
41396 100 0.014 2 AZITHROMYCIN PO 15.88
41396 100 1.821 3 CEFTRIAXONE IV 18.43
41396 100 0.000 4 CEFUROXIME IV 1.89
41396 100 0.040 5 CIPROFLOXACIN PO 2.7
41396 100 0.123 6 ERITHROMYCIN PO 2.73
41396 100 15.875 7 ETAMBUTOL PO 2.26
41396 100 0.040 8 ISONIAZID PO 4.39
41396 100 0.844 9 LEVOFLOXACIN IV 19.52
41396 100 0.678 10 RIFAMPISIN PO 2.21
41396 100 0.100
41396 100 0.111
41396 100 1.476
41396 100 1.138
41396 100 18.428
41396 100 1.892
41396 100 0.001
41396 100 1.278 AUDIT KUANTITATIF PENGGUNAAN ANTIBIOTIK DENG
41396 100 2.700 METODE DDD TAHUN 2021 SECARA ACAK
41396 100 0.060 PADA 10 BESAR ANTIBIOTIK
18.43 1
41396 100 0.928
20 15.88
41396 100 0.059
41396 100 0.205 15
41396 100 0.718
10
41396 100 0.062 4.39
5 1.82 1.89 2.7 2.73 2.26
41396 100 0.841
41396 100 2.731
0
41396 100 2.262 IV V
PO PO E EI PO PO P O PO N
41396 100 0.000 I N I N
ON I M I N I N OL ZI
D
AC
I
LL YC X OX AC YC UT IA
CI IA X OX
0.334 I OM R R
LO RO
M B
ON L
41396 100 OX HR FT FU F AM IS F
M IT CE CE RO IT
H ET VO
0.000
A
AZ IP ER LE
41396 100 C
41396 100 4.388 TOTAL NILAI DDD (%)
41396 100 0.051
41396 100 0.055
41396 100 0.000
41396 100 19.515
41396 100 1.045 TRIWULAN NILAI TOTAL DDD (%)
41396 100 0.330 I 28.46
41396 100 1.448 II 24.08
41396 100 3.224 III 25.32
41396 100 1.605 IV 21.53
41396 100 0.029
41396 100 0.090
41396 100 1.257
41396 100 2.213
41396 100 0.600
41396 100 0.620
41396 100 0.002 28.46
30 25.32
24.08
25 21.53

20

15

10

0
NILAI TOTAL DDD (%)
 TOTAL
NILAI TOTAL NILAI
KODE ATC NAMA ANTIBIOTIK DDD ALL LOS % DDD
J01GB06 AMIKASIN IV 2.14 13206 100 0.016
J01CA04 AMOXICILLIN IV 2 13206 100 0.015
J01CA04 AMOXICILLIN PO 228.9 13206 100 1.733
J01CA01 AMPICILIN IV 0 13206 100 0
J01CA01 AMPICILIN SULBACTAM IV 2.25 13206 100 0.017
J01MB03 ASAM PIPEMIDIC PO 33 13206 100 0.25
J01FA10 AZITHROMICIN PO 48.55 13206 100 0.368
J01DB05 CEFADROXIL PO 2.14 13206 100 0.016
J01DB04 CEFAZOLIN IV 146 13206 100 1.106
J01DD08 CEFIXIME PO 81.36 13206 100 0.616
J01DD12 CEFOPERAZONE IV 32.5 13206 100 0.246
J01DD12 CEFOPERAZONE-SULBACTAM 24 13206 100 0.182
J01DD01 CEFOTAXIME IV 202.13 13206 100 1.531
J01DD02 CEFTAZIDIM IV 88.14 13206 100 0.667
J01DD04 CEFTRIAXONE IV 2842.83 13206 100 21.527
J01DC02P CEFUROXIME IV 229.03 13206 100 1.734
J01DC02P CEFUROXIME PO 0 13206 100 0
J01MA02P CIPROFLOXACIN IV 200.5 13206 100 1.518
J01MA02 CIPROFLOXACIN PO 514.8 13206 100 3.898
J01FA09 CLARITHROMICIN PO 1.02 13206 100 0.008
J01FF01 CLINDAMICIN PO 141.05 13206 100 1.068
J01CR02 CO AMOXICLAV IV 0 13206 100 0
J01CR02 CO AMOXICLAV PO 12.5 13206 100 0.095
J01EE01 COTRIMOXAZOL PO 110.11 13206 100 0.834
J01GB09 DIBEKASIN IV 2.86 13206 100 0.022
J01AA02 DOXICYCLINE PO 144 13206 100 1.09
J01FA01 ERITHROMICIN PO 338.9 13206 100 2.566
J04AK02 ETAMBUTOL PO 494.67 13206 100 3.746
J01XX01 FOSFOMYCIN IV 0 13206 100 0
J01GB03 GENTAMICIN IV 47.07 13206 100 0.356
J04AC01 IMIPENEM-CILASTATIN IV 0 13206 100 0
J01DH51 ISONIAZID PO 1141.5 13206 100 8.644
J01GB04 KANAMICIN IV 4 13206 100 0.03
J01BA01 KHLORAMPENICOL IV 0 13206 100 0
J01BA02 KHLORAMPENICOL PO 0 13206 100 0
J01MA12 LEVOFLOXACIN IV 789 13206 100 5.975
J01MA12 LEVOFLOXACIN PO 49.5 13206 100 0.375
J01FF02 LINKOMYCIN PO 48.3 13206 100 0.366
J01DH02 MEROPENEM IV 89.75 13206 100 0.68
J01XD01 METRONIDAZOL IV 360.8 13206 100 2.732
 P01AB01 METRONIDAZOL PO 163.28 13206 100 1.236
J01MA01 OFLOXACIN PO 10 13206 100 0.076
J01CA12 PIPERACILLIN-TAZOBACTAM I 11.57 13206 100 0.088
J04AK01 PYRAZINAMID PO 289.2 13206 100 2.19
J04AB02 RIFAMPISIN PO 474.08 13206 100 3.59
J01F02 SPIRAMICIN PO 133 13206 100 1.007
J01BA02 THIAMPENICOL PO 59 13206 100 0.447

GGUNAAN ANTIBIOTIK DENGAN

HUN 2021 SECARA ACAK
ESAR ANTIBIOTIK
19.52

4.39
2.7 2.73 2.26 2.21

PO PO P O PO IV PO
N
CI
N I N OL ZI
D CI S IN
YC UT IA XA PI
M B
RO AM ON FL
O
AM
IS RI
F
IT
H ET VO
ER LE

L NILAI DDD (%)

 LEVOFLOXACIN IV
LEVOFLOXACIN IV
LEVOFLOXACIN IV
CEFTRIAXONE IV

21.53

I
II
III
IV
 NILAI TOTAL
NO ANTIBIOTIK DDD (%)
1 AMOXICILLIN PO 8.682
2 AZITHROMYCIN PO 0.896
3 CEFADROXIL PO 0.119
4 CEFAZOLIN IV 3.963 AUDIT KUANTITATIF PENGGUNAAN AN
5 CEFIXIME PO 0.179 METODE DDD SECARA ACAK PADA BAG
6 CEFTRIAXONE IV 9.886 WULAN II TAHUN 202
7 CO AMOXICLAV PO 1.469
20
8 ERITHROMYCIN PO 16.816
9 METRONIDAZOLE PO 7.019 15
9.886
8.682
10 METRONIDAZOLE IV 6.641 10
3.963
5 0.896 0.119 1
0.179
0
PO PO O IV O IV
I N IN I LP LI
N EP NE AV
P
LL YC OX ZO IM XO L
CI DR A IX IA IC
I OM F
CE
F R OX
OX HR FA CE FT
AM IT C E CE AM I T
AZ CO ER

NILAI TOTAL DDD (%)

ANTITATIF PENGGUNAAN ANTIBIOTIK DENGAN
DDD SECARA ACAK PADA BAGIAN OBSGYN TRI-
WULAN II TAHUN 2021

16.816

9.886
7.019 6.641
3.963
6 0.119 1.469
0.179

O IV O IV PO PO PO IV
I LP LI
N EP NE V IN LE LE
OX ZO X IM XO C LA YC ZO ZO
A FI IA I M A DA
CE
F
CE FT
R OX O
NI
D NI
CE
M HR RO
A IT RO ET
CO ER ET M
M
NILAI TOTAL DDD (%)